While there have been multiple attempts to overcome MGMT-mediated TMZ resistance in glioma cells, by means such as siRNA (6), enzymatic inhibition (7) or knock-out (8), the specific induction of individual CpG methylation has so far not been recreated in a laboratory environment. This evidence concerns the gene MGMT and central nervous system cancer.